Deferasirox 360mg tablets
NHS hospitals in England used £18,391,330 of indicative cost of Deferasirox 360mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 2.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Deferasirox 360mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Deferasirox 360mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University College London Foundation Tr | £1,722,857 |
| The Whittington Health Nhs Trust | £1,610,986 |
| Barts Health Nhs Trust | £967,428 |
| Manchester University Nhs Ft | £860,244 |
| Sandwell And West Birmingham Hpls Trust | £853,810 |
| Guy's & St Thomas' Nhs Foundation Trust | £574,409 |
| King's College Hpl Nhs Foundation Trust | £569,050 |
| Nottingham University Hospitals Trust | £410,945 |
| Imperial College Healthcare Nhs Trust | £399,067 |
| University Hpls Of Leicester Nhs Trust | £352,800 |
The primary-care picture
Deferasirox is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Deferasirox medicine page.